Endonovo Therapeutics, Inc. (OTCMKTS:ENDV) Short Interest Update

Endonovo Therapeutics, Inc. (OTCMKTS:ENDV) was the target of a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 100,000 shares, a growth of 15.2% from the November 15th total of 86,800 shares. Based on an average daily volume of 14,295,400 shares, the days-to-cover ratio is currently 0.0 days.

Endonovo Therapeutics Price Performance

OTCMKTS:ENDV traded down $0.00 during mid-day trading on Monday, hitting $0.00. 22,700,604 shares of the stock were exchanged, compared to its average volume of 2,135,619. Endonovo Therapeutics has a fifty-two week low of $0.00 and a fifty-two week high of $0.01.

About Endonovo Therapeutics

Endonovo Therapeutics, Inc, a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema.